Skip to main content

16. Links Between Financial Statements and Regulatory Exposures

No: 44047144 Date(g): 27/12/2022 | Date(h): 4/6/1444 Status: In-Force
 16.1This chapter describes requirements for banks to disclose reconciliations between elements of the calculation of regulatory capital to audited financial statements.
 
 16.2The disclosure requirements set out in this chapter are:
 
  16.2.1Table LIA - Explanations of differences between accounting and regulatory exposure amounts
 
  16.2.2Template LI1 - Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories
 
  16.2.3Template LI2 - Main sources of differences between regulatory exposure amounts and carrying values in financial statements
 
  16.2.4Template PV1 - Prudent valuation adjustments (PVAs)
 
 16.3Table LIA provides qualitative explanations on the differences observed between accounting carrying value (as defined in Template LI1) and amounts considered for regulatory purposes (as defined in Template LI2) under each framework.
 
Table LIA: Explanations of differences between accounting and regulatory exposure amounts
Purpose: Provide qualitative explanations on the differences observed between accounting carrying value (as defined in Template LI1) and amounts considered for regulatory purposes (as defined in Template LI2) under each framework.
Scope of application: The template is mandatory for all banks.
Content: Qualitative information.
Frequency: Annual.
Format: Flexible.
Banks must explain the origins of the differences between accounting amounts, as reported in financial statements amounts and regulatory exposure amounts, as displayed in Templates LI1 and LI2.
(a)Banks must explain the origins of any significant differences between the amounts in columns (a) and (b) in Template LI1.
(b)Banks must explain the origins of differences between carrying values and amounts considered for regulatory purposes shown in Template LI2.
(c)In accordance with the implementation of the guidance on prudent valuation (see Basel Framework “prudent valuation guidance”), banks must describe systems and controls to ensure that the valuation estimates are prudent and reliable. Disclosure must include:
 Valuation methodologies, including an explanation of how far mark-to-market and mark-to-model methodologies are used.
 Description of the independent price verification process.
 Procedures for valuation adjustments or reserves (including a description of the process and the methodology for valuing trading positions by type of instrument).
(d)Banks with insurance subsidiaries must disclose:
 The national regulatory approach used with respect to insurance entities in determining a bank's reported capital positions (ie deduction of investments in insurance subsidiaries or alternative approaches, as discussed in Basel Framework “Scope and definitions” Banking, securities and other financial subsidiaries (Insurance entities); and
 Any surplus capital in insurance subsidiaries recognized when calculating the bank's capital adequacy (see Basel Framework “Scope and definitions” Banking, securities and other financial subsidiaries (Insurance entities).
 
Template LI1: Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories
Purpose: Columns (a) and (b) enable users to identify the differences between the scope of accounting consolidation and the scope of regulatory consolidation; and columns (c)-(g) break down how the amounts reported in banks' financial statements (rows) correspond to regulatory risk categories.
Scope of application: The template is mandatory for all banks.
Content: Carrying values (corresponding to the values reported in financial statements).
Frequency: Annual.
Format: Flexible (but the rows must align with the presentation of the bank's financial report).
Accompanying narrative: See Table LIA. Banks are expected to provide qualitative explanation on items that are subject to regulatory capital charges in more than one risk category.
 
 abcdefg
Carrying values as reported in published financial statementsCarrying values under scope of regulatory consolidationCarrying values of items:
Subject to credit risk frameworkSubject to counterparty credit risk frameworkSubject to the securitization frameworkSubject to the market risk frameworkNot subject to capital requirements or subject to deduction from capital
Assets       
Cash and balances at central banks       
Items in the course of collection from other banks       
Trading portfolio assets       
Financial assets designated at fair value       
Derivative financial instruments       
Loans and advances to banks       
Loans and advances to customers       
Reverse repurchase agreements and other similar secured lending       
Available for sale financial investments       
-.       
Total assets       
Liabilities       
Deposits from banks       
Items in the course of collection due to other banks       
Customer accounts       
Repurchase agreements and other similar secured borrowings       
Trading portfolio liabilities       
Financial liabilities designated at fair value       
Derivative financial instruments       
-.       
Total liabilities       
 

Instructions

Rows

The rows must strictly follow the balance sheet presentation used by the bank in its financial reporting.

Columns

If a bank's scope of accounting consolidation and its scope of regulatory consolidation are exactly the same, columns (a) and (b) should be merged.

The breakdown of regulatory categories (c) to (f) corresponds to the breakdown prescribed in the rest of SDIS, ie column (c) corresponds to the carrying values of items other than off-balance sheet items reported in section 19 column (d) corresponds to the carrying values of items other than off-balance sheet items reported in section 20, column (e) corresponds to carrying values of items in the banking book other than off-balance sheet items reported in section 21 and column (f) corresponds to the carrying values of items other than off-balance sheet items reported in section 22.

Column (g) includes amounts not subject to capital requirements according to the Basel framework or subject to deductions from regulatory capital.

Note: Where a single item attracts capital charges according to more than one risk category framework, it should be reported in all columns that it attracts a capital charge. As a consequence, the sum of amounts in columns (c) to (g) may not equal the amounts in column (b) as some items may be subject to regulatory capital charges in more than one risk category.

For example, derivative assets/liabilities held in the regulatory trading book may relate to both column (d) and column (f). In such circumstances, the sum of the values in columns (c)-(g) would not equal to that in column (b). When amounts disclosed in two or more different columns are material and result in a difference between column (b) and the sum of columns (c)-(g), the reasons for this difference should be explained by banks in the accompanying narrative.
 
Template LI2: Main sources of differences between regulatory exposure amounts and carrying values in financial statements
Purpose: Provide information on the main sources of differences (other than due to different scopes of consolidation which are shown in Template LI1) between the financial statements' carrying value amounts and the exposure amounts used for regulatory purposes.
Scope of application: The template is mandatory for all banks.
Content: Carrying values that correspond to values reported in financial statements but according to the scope of regulatory consolidation (rows 1-3) and amounts considered for regulatory exposure purposes (row 10).
Frequency: Annual.
Format: Flexible. Row headings shown below are provided for illustrative purposes only and should be adapted by the bank to describe the most meaningful drivers for differences between its financial statement carrying values and the amounts considered for regulatory purposes.
Accompanying narrative: See Table LIA
 
 abcde
TotalItems subject to:
Credit risk frameworkSecuritization frameworkCounterparty credit risk frameworkMarket risk framework
1Asset carrying value amount under scope of regulatory consolidation (as per Template LI1)     
2Liabilities carrying value amount under regulatory scope of consolidation (as per Template LI1)     
3Total net amount under regulatory scope of consolidation (Row 1 - Row 2)     
4Off-balance sheet amounts     
5Differences in valuations    
6Differences due to different netting rules, other than those already included in row 2    
7Differences due to consideration of provisions    
8Differences due to prudential filters    
9    
10Exposure amounts considered for regulatory purposes    
 

Instructions

Amounts in rows 1 and 2, columns (b)-(e) correspond to the amounts in columns (c)-(f) of Template LI1.

Row 1 of Template LI2 includes only assets that are risk-weighted under the Basel framework, while row 2 includes liabilities that are considered for the application of the risk weighting requirements, either as short positions, trading or derivative liabilities, or through the application of the netting rules to calculate the net position of assets to be risk-weighted. These liabilities are not included in column (g) in Template LI1. Assets that are risk weighted under the Basel framework include assets that are not deducted from capital because they are under the applicable thresholds or due to the netting with liabilities.

Off-balance sheet amounts include off-balance sheet original exposure in column (a) and the amounts subject to regulatory framework, after application of the credit conversion factors (CCFs) where relevant in columns (b)-(d).

Column (a) is not necessarily equal to the sum of columns (b)-(e) due to assets being risk-weighted more than once (see Template LI1). In addition, exposure values used for risk weighting may differ under each risk framework depending on whether standardized approaches or internal models are used in the computation of this exposure value. Therefore, for any type of risk framework, the exposure values under different regulatory approaches can be presented separately in each of the columns if a separate presentation eases the reconciliation of the exposure values for banks.

The breakdown of columns in regulatory risk categories (b)-(e) corresponds to the breakdown prescribed in the rest of the document, ie column (b) credit risk corresponds to the exposures reported in section 19, column (c) corresponds to the exposures reported in section 21, column (d) corresponds to exposures reported in section 20, and column (e) corresponds to the exposures reported in section 22.

Differences due to consideration of provisions: The exposure values under row 1 are the carrying amounts and hence net of provisions (ie specific and general provisions, as set out in SACAP2.2.3). Nevertheless, exposures under the foundation internal ratings-based (F-IRB) and advanced internal ratings-based (A-IRB) approaches are risk-weighted gross of provisions. Row 7 therefore is the re-inclusion of general and specific provisions in the carrying amount of exposures in the F-IRB and A-IRB approaches so that the carrying amount of those exposures is reconciled with their regulatory exposure value. Row 7 may also include the elements qualifying as general provisions that may have been deducted from the carrying amount of exposures under the standardized approach and that therefore need to be reintegrated in the regulatory exposure value of those exposures. Any differences between the accounting impairment and the regulatory provisions under the Basel framework that have an impact on the exposure amounts considered for regulatory purposes should also be included in row 7.

Exposure amounts considered for regulatory purposes: The expression designates the aggregate amount considered as a starting point of the RWA calculation for each of the risk categories. Under the credit risk framework this should correspond either to the exposure amount applied in the standardized approach for credit risk (see SCRE5) or to the exposures at default (EAD) in the IRB approach for credit risk (see SCRE12.29); securitization exposures should be defined as in the securitization framework (see SCRE18.4 and SCRE18.5); and counterparty credit exposures are defined as the EAD considered for counterparty credit risk purposes (see SCCR5).

Linkages across templates

 
Template LI2 is focused on assets in the regulatory scope of consolidation that are subject to the regulatory framework. Therefore, column (g) in Template LI1, which includes the elements of the balance sheet that are not subject to the regulatory framework, is not included in Template LI2. The following linkage holds: column (a) in Template LI2 = column (b) in Template LI1 - column (g) in Template LI1.
 
Template PV1: Prudent valuation adjustments (PVAs)
Purpose: Provide a breakdown of the constituent elements of a bank's PVAs according to the requirements of Basel Framework “prudent valuation guidance”, taking into account SAMA’s circular No. 301000000768 on Supervisory guidance for assessing banks' financial instrument fair value practices, July 2009.
Scope of application: The template is mandatory for all banks which record PVAs.
Content: PVAs for all assets measured at fair value (marked to market or marked to model) and for which PVAs are required. Assets can be non-derivative or derivative instruments.
Frequency: Annual.
Format: Fixed. The row number cannot be altered. Rows which are not applicable to the reporting bank should be filled with "0" and the reason why they are not applicable should be explained in the accompanying narrative.
Accompanying narrative: Banks are expected to supplement the template with a narrative commentary to explain any significant changes over the reporting period and the key drivers of such changes. In particular, banks are expected to detail "Other adjustments", where significant, and to define them when they are not listed in the Basel framework. Banks are also expected to explain the types of financial instruments for which the highest amounts of PVAs are observed.
 
 abcdefgh
EquityInterest ratesForeign exchangeCreditCommoditiesTotalOf which: in the trading bookOf which: in the banking book
1Closeout uncertainty, of which:        
2Mid-market value        
3Closeout cost        
4Concentration        
5Early termination        
6Model risk        
7Operational risk        
8Investing and funding costs    
9Unearned credit spreads   
10Future administrative costs        
11Other        
12Total adjustment        
 
Definitions and instructions
 
Row NumberExplanation
3Closeout cost: PVAs required to take account of the valuation uncertainty to adjust for the fact that the position level valuations calculated do not reflect an exit price for the position or portfolio (for example, where such valuations are calibrated to a mid-market price).
4Concentration: PVAs over and above market price and closeout costs that would be required to get to a prudent exit price for positions that are larger than the size of positions for which the valuation has been calculated (i.e. cases where the aggregate position held by the bank is larger than normal traded volume or larger than the position sizes on which observable quotes or trades that are used to calibrate the price or inputs used by the core valuation model are based).
5Early termination: PVAs to take into account the potential losses arising from contractual or non-contractual early terminations of customer trades that are not reflected in the valuation.
6Model risk: PVAs to take into account valuation model risk which arises due to: (i) the potential existence of a range of different models or model calibrations which are used by users of Pillar 3 data; (ii) the lack of a firm exit price for the specific product being valued; (iii) the use of an incorrect valuation methodology; (iv) the risk of using unobservable and possibly incorrect calibration parameters; or (v) the fact that market or product factors are not captured by the core valuation model.
7Operational risk: PVAs to take into account the potential losses that may be incurred as a result of operational risk related to valuation processes.
8Investing and funding costs: PVAs to reflect the valuation uncertainty in the funding costs that other users of Pillar 3 data would factor into the exit price for a position or portfolio. It includes funding valuation adjustments on derivatives exposures.
9Unearned credit spreads: PVAs to take account of the valuation uncertainty in the adjustment necessary to include the current value of expected losses due to counterparty default on derivative positions, including the valuation uncertainty on CVA.
10Future administrative costs: PVAs to take into account the administrative costs and future hedging costs over the expected life of the exposures for which a direct exit price is not applied for the closeout costs. This valuation adjustment has to include the operational costs arising from hedging, administration and settlement of contracts in the portfolio. The future administrative costs are incurred by the portfolio or position but are not reflected in the core valuation model or the prices used to calibrate inputs to that model.
11Other: "Other" PVAs which are required to take into account factors that will influence the exit price but which do not fall in any of the categories listed in Basel Framework “prudent valuation guidance” (Introduction). These should be described by banks in the narrative commentary that supports the disclosure.
 
Linkages across templates
[PV1:12/f] is equal to [CC1:7/a]